26 July 2021 | News
The partners will build a framework of well-regulated workflows for advanced gene panels
Image Credit: Shutterstock
Bengaluru-based startup 4baseCare has partnered with Wipro to develop precision oncology solutions that will improve the affordability and timely availability of gene testing reports for cancer patients.
4baseCare and Wipro will jointly pave the way for cancer patients to gain access to advanced genomic testing at an affordable cost and reduce the turnaround time (TAT) on test results to almost half from the current market average of 30 days.
The partners will build a framework of efficient, streamlined, and well-regulated workflows for the development of advanced gene panels.
Hitesh Goswami, Founder and CEO, 4baseCare, said, “We look forward to fighting cancer through technology, research and collaboration."
Through this partnership, oncologists, cancer hospitals and cancer clinics can tap diagnostics and prognostics cancer gene panels at an economical price point. It can help them identify and understand the genetic mutation of cancer, and design treatments to specifically target these mutations. The 4baseCare-Wipro partnership will help with patient recovery and create economic dividends for the nation at large.